UPCOMING WEBINAR:
Addressing Direct-to-Patient Clinical Supply Challenges Through Speed and Flexibility
Tuesday, April 20th | 9:00am EST | 15:00 CET
Covid-19 has led to accelerated development in Direct-to-Patient (DtP) models for clinical trial studies, creating a growing need for cutting-edge technologies that allow for safe and rapid integration of these models. Delivering IMP to a patients’ home requires speed and flexibility to allow for seamless collaboration between the study team, sites, and depots on logistical challenges. Join Neta Bendelac from 4G Clinical and Limor Teomim from IMP CSS for an informative webinar as they explore how to mitigate the growing challenges faced as a result of the pandemic when it comes to DtP strategies and virtual trial design.
Webinar Objectives:
• Introduce and assess DtP models within a clinical trial
• Discuss industry challenges with DtP models in the current landscape
• Explore flexible DtP designs in modern Randomization and Trial Supply Management (RTSM) systems
• Explore the future of decentralized clinical trial design
Secure Your Seat
Today!
Presenters
|
|
|
|
|
|
Neta Bendelac Senior Director, Strategy 4G Clinical
|
|
Limor Teomim CEO |
|
Additional Resources
Modern Technologies
in Clinical Trials
Demystifying the use of Innovative RTSMs in a Highly-Regulated Environment